EVH: Amendment: SEC Form SCHEDULE 13G/A filed by Evolent Health Inc
Stocks in this Quantisnow insightConsumer Discretionary
Historical context for EVH
Across the 16 sessions after earlier EVH headlines, the stock closed higher 9 times and lower 7 times, with a median move of 5.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | EVH | SPY |
|---|---|---|---|
| Aug 11, 2026 | Evolent Health upgraded by Citigroup with a new price target | +4.3% | -0.3% |
| Aug 6, 2026 | Evolent Announces Second Quarter 2026 Results | +16.6% | -0.2% |
| Jul 23, 2026 | Evolent Health downgraded by Citigroup with a new price target | -16.7% | -1.2% |
| Jul 9, 2026 | Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | +0.5% | +0.8% |
| Jun 30, 2026 | Evolent Health downgraded by Truist with a new price target | -6.1% | +0.8% |
| May 12, 2026 | Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer | +5.1% | -0.2% |
Quantisnow market dataNYSE
EVH
Evolent Health Inc
- Market cap
- 30-day
- Sector
- Consumer Discretionary
- Industry
- Other Consumer Services
- Listed since
- 2015
Get push alerts for EVH
Full EVH profile on Quantisnow Follow EVH and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time